NASDAQ · Biotechnology

MRKR (MRKR) Stock

$1.19 -2.46% NASDAQ: MRKR Healthcare

Valuation

MetricValue
Price$1.19
Market Cap$12.85M
P/E Ratio-1.80
P/B Ratio0.86
P/S Ratio6.96
EPS (TTM)$-0.79
52-Week High$4.07
52-Week Low$0.81
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-70.59%
ROA-63.16%
ROCE-76.47%
Gross Margin-65.14%
Operating Margin-3.86%
Net Margin-520.35%
Debt/Equity0.00
Current Ratio8.39

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$4.0M$3.0M$7.0M$0
Operating Profit$-39.0M$-20.0M$-15.0M$-11.0M$-13.0M
Net Profit$-42.0M$-30.0M$-8.0M$-11.0M$-12.0M
EPS$-5.47$-3.58$-1.93$-1.19$-0.79
Op Margin-3179.3%-563.3%-440.4%-168.7%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$68.0M$34.0M$17.0M$22.0M$19.0M
Total Liabilities$24.0M$15.0M$3.0M$3.0M$2.0M
Cash$42.0M$12.0M$15.0M$19.0M$16.0M
Borrowings$12.0M$8.0M$0$0$0

Latest News

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker Zacks · Jun 26, 2026 5 Small Drug Stocks to Invest in Amid a Biotech Comeback Zacks · Jun 25, 2026 Exploring 3 High Growth Tech Stocks in US Market Simply Wall St. · Jun 15, 2026 Exploring High Growth Tech Stocks In The US Market Simply Wall St. · Jun 11, 2026 Exploring 3 High Growth Tech Stocks in the US Market Simply Wall St. · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-27.0M$-27.0M$-16.0M$-11.0M$-12.0M
Investing Cash Flow$-6.0M$-5.0M$19.0M$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$22.0M$-32.0M$3.0M$4.0M$-2.0M
Free Cash Flow$-30.0M$-27.0M$-16.0M$-11.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-54.32%
Quick Ratio4.79
Interest Coverage—
Return 1Y-10.19%
Return 3Y-73.19%
Return 5Y-93.68%

Ownership

Insiders Held5.49%
Institutions Held23.31%
Institutions Float Held24.66%
Institutional HolderSharesReport Date
NEA Management Company, LLC1,625,6782026-03-31
Blue Owl Capital Holdings LP554,2502026-03-31
Vanguard Capital Management LLC389,3192026-03-31
Aisling Capital Management LP325,3702026-03-31
Renaissance Technologies, LLC175,2942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AEONAEON Biopharma, Inc. $0.24 -5.50% -0.05 $2.80M 0.00%
BOLT $3.95 -0.50% -0.26 $7.59M 0.00%
CLRB $2.37 -2.07% -0.38 $7.57M 0.00%
COCP $0.92 +0.14% -1.46 $12.68M 0.00%
EVGNEvogene Ltd. $0.54 -0.04% -0.41 $4.67M 0.00%

About MRKR

MRKR is led by CEO Juan F. Vera, employs 5 people, headquartered in US, publicly traded since 2002.

MRKR stock trades at $1.19 with a market capitalization of $12.85M. The stock is valued at a price-to-earnings (P/E) ratio of -1.80, price-to-book of 0.86, price-to-sales of 6.96. Over the past 52 weeks the stock has ranged between $0.81 and $4.07, and currently trades 70.8% below its 52-week high.

On profitability, MRKR generates a return on equity (ROE) of -70.59%, return on capital employed of -76.47%, an operating margin of -3.86%, a net profit margin of -520.35%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides